GlycoNovo Technologies Co., Ltd. 


Glycoscience, the study of glycan and glycosylate biomolecules, now is the new frontier in the bioscience in the post-genomic era after the completion of the Human Genome Project (HGP).


GlycoNovo specializes in the creation of new methodologies, the development and production of unique high quality reliable chemical and biological reagents, to better the glycoscience work, and carbohydrate-based biomarker and new drug discovery. 


Read more

  • 01
  • 02
  • 03

news / 2018.06.22

New products on recombinant Glycosaminoglycan (GAG) Degrading Enzymes are released now!

New products on Glycosaminoglycan (GAG) Degrading Enzymes are released now!
Read more

news / 2018.06.22

New products on heparin derivatives are released now!

New products on heparin derivatives are released now!
Read more

news / 2018.06.22

The website of GlycoNovo is online now!

Our website is online now!
Read more

© 2020 GlycoNovo Technologies Co., Ltd. All Rights Reserved.
TERMS AND CONDITIONS OF SALE|PRIVACY POLICY